• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by The Pennant Group Inc.

    5/2/25 4:15:45 PM ET
    $PNTG
    Medical/Nursing Services
    Health Care
    Get the next $PNTG alert in real time by email
    DEFA14A 1 fy2025definitiveadditional.htm DEFA14A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 14A
    (Rule 14a-101)
    SCHEDULE 14A INFORMATION
    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934 (Amendment No. 2)
    Filed by the Registrant þ
    Filed by a Party other than the Registrant o
    Check the appropriate box:
    o Preliminary Proxy Statement
     
    o 
    Confidential, For Use of the Commission only (as permitted by Rule 14a- 6(e)(2))
     
    o Definitive Proxy Statement
     
    þ Definitive Additional Materials
     
    o Soliciting Material Pursuant to §240.14a-12
    THE PENNANT GROUP, INC.
    (Name of Registrant as Specified in Its Charter)
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check all boxes that apply):

    þNo fee required
    oFee paid previously with preliminary materials.
    oFee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.





    pennant_finala.jpg

    THE PENNANT GROUP, INC.
    1675 E. Riverside Drive, Suite 150
    Eagle, Idaho 83616
     
    AMENDMENT NO. 2
    TO OUR PROXY STATEMENT FOR OUR ANNUAL MEETING OF STOCKHOLDERS
    TO BE HELD ON MAY 16, 2025

    May 2, 2025
     
    This Amendment No. 2 (this “Amendment”) amends the proxy statement of The Pennant Group, Inc. (the “Company”) dated April 17, 2025 (the “Proxy Statement”). This Amendment does not change the proposals to be acted on at the 2025 Annual Meeting of Stockholders of the Company (the “Annual Meeting”), or the recommendations of the board of directors of the Company (the “Board”) in relation thereto, which are described in the Proxy Statement.

    The purpose of this Amendment is to clarify the required vote with respect to Proposal 2. Proposal 2 requires the affirmative vote of a majority of the outstanding shares of common stock entitled to vote on the amendment to the certificate of incorporation. The table in the section entitled “Vote Required to Approve Proposals” is hereby amended with respect to Proposal 2 as shown below (with additions shown by underline formatting and deletions shown by strike-through formatting):

    ProposalVote Required for ApprovalEffect of AbstentionsEffect of Broker Non-Votes
    Proposal 1. Election of director nominees
    Majority of votes cast with respect to each directorNo effectNo effect
    Proposal 2. Approval of amended certificate of incorporation
    Majority of voting power present and the outstanding stock entitled to vote at the meeting
    Against
    No effect
    Against
    Proposal 3. Approval of amended omnibus incentive plan
    Majority of voting power present and entitled to vote at the meetingAgainstNo effect
    Proposal 4. Approval of independent accounting firm
    Majority of voting power present and entitled to vote at the meeting AgainstNo effect
    Proposal 5. Advisory vote to approve named executive officer compensation (“Say-on-Pay”)
    Majority of voting power present and entitled to vote at the meeting AgainstNo effect

    Unless otherwise expressly provided for in this Amendment, all capitalized words, phrases, or defined terms used in this Amendment will have the same meaning ascribed to them in the Proxy Statement. Except as expressly set forth in this Amendment, there have been no other changes or modifications to the Proxy Statement, and the Proxy Statement remains otherwise unchanged and in full force and effect.

    The Company has filed a definitive proxy statement with the Securities and Exchange Commission (“SEC”) and has furnished to its stockholders a proxy statement in connection with the solicitation of proxies for the Annual Meeting. The Company advises its stockholders to read the Proxy Statement relating to the Annual Meeting, as amended and supplemented by this Amendment, because it contains important information. Stockholders may obtain a free copy of the Proxy Statement and other documents that the Company files with the SEC at the SEC’s website at www.sec.gov.

    Get the next $PNTG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PNTG

    DatePrice TargetRatingAnalyst
    12/19/2024$33.00Equal Weight
    Wells Fargo
    1/5/2024$14.00 → $18.00Equal-Weight → Overweight
    Stephens
    2/27/2023$15.00 → $16.00Hold → Buy
    Stifel
    8/25/2022$22.00Outperform
    Oppenheimer
    6/21/2022$23.00 → $17.00Overweight → Equal-Weight
    Stephens
    3/10/2022$37.00 → $26.00Outperform
    RBC Capital
    3/2/2022$33.00 → $26.00Overweight
    Stephens & Co.
    3/1/2022$32.00 → $18.00Buy → Hold
    Stifel
    More analyst ratings